Based on that evidence, we aimed to assess plasma OXT in BPD patients before and during two different psychotherapeutic protocols and to correlate the neuropeptide levels with symptom improvement during treatment, clinical characteristics, and childhood stress exposure. Here, OXT is linked to Borderline personality disorder.